1. Home
  2. SWX vs PRAX Comparison

SWX vs PRAX Comparison

Compare SWX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

HOLD

Current Price

$89.17

Market Cap

6.3B

Sector

Utilities

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$314.00

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWX
PRAX
Founded
1931
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
SWX
PRAX
Price
$89.17
$314.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
$87.40
$572.13
AVG Volume (30 Days)
490.5K
530.1K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.70%
N/A
EPS Growth
120.29
N/A
EPS
1.91
N/A
Revenue
$5,433,972,000.00
N/A
Revenue This Year
$18.48
N/A
Revenue Next Year
$2.61
$7,758.26
P/E Ratio
$46.62
N/A
Revenue Growth
9.56
N/A
52 Week Low
$72.43
$37.25
52 Week High
$94.43
$366.52

Technical Indicators

Market Signals
Indicator
SWX
PRAX
Relative Strength Index (RSI) 53.49 57.14
Support Level $87.55 $308.40
Resistance Level $89.58 $327.65
Average True Range (ATR) 1.48 17.21
MACD 0.22 6.98
Stochastic Oscillator 79.95 97.65

Price Performance

Historical Comparison
SWX
PRAX

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: